@article{article, title  = {{Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy}},

 publisher = {{MDPI AG}},

 url = {{http://dx.doi.org/10.3390/cancers13194846 }},

 year = {{2021}},

 month = {{9}},

 author = {{Mouritzen MT and Carus A and Ladekarl M and Meldgaard P and Nielsen AWM and Livbjerg A and Larsen JW and Skuladottir H and Kristiansen C and Wedervang K and Schytte T et al}},

 doi = {{10.3390/cancers13194846}},

 volume = {{13}},

 journal = {{Cancers}},

 issue = {{19}},

 pages = {{4846-4846}},

 note = {{Accessed on 2024/12/22}}}